NABI-HB (Biotest Pharmaceuticals Corporation)


Welcome to the PulseAid listing for the NABI-HB drug offered from Biotest Pharmaceuticals Corporation. This Human Immunoglobulin [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Biotest Pharmaceuticals Corporation
NON-PROPRIETARY NAME: HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
SUBSTANCE NAME: HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Human Immunoglobulin [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2010-03-10
END MARKETING DATE: 0000-00-00


NABI-HB HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNABI-HB from Biotest Pharmaceuticals Corporation
LABELER NAME: Biotest Pharmaceuticals Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 312([iU]/mL)
START MARKETING DATE: 2010-03-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59730-4202_b2145184-7093-495f-a36b-8bf1d56b6a09
PRODUCT NDC: 59730-4202
APPLICATION NUMBER: BLA991442

Other HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aptevo BioTherapeutics LLCHepaGam B
Biotest Pharmaceuticals CorporationNABI-HB
Cangene bioPharma Inc.HepaGam B
Cangene BioPharma, LLCHepaGam B
GRIFOLS USA, LLCHYPERHEP B